161 related articles for article (PubMed ID: 32963642)
1. Survival Analysis of Risk Factors for Mortality in a Cohort of Patients with Tuberculosis.
Xie Y; Han J; Yu W; Wu J; Li X; Chen H
Can Respir J; 2020; 2020():1654653. PubMed ID: 32963642
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis-associated mortality and its risk factors in a district of Shanghai, China: a retrospective cohort study.
Liu Y; Zheng Y; Chen J; Shi Y; Shan LY; Wang S; Wang WB; Shen X; Zhang Y
Int J Tuberc Lung Dis; 2018 Jun; 22(6):655-660. PubMed ID: 29862950
[TBL] [Abstract][Full Text] [Related]
3. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
Kliiman K; Altraja A
Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
[TBL] [Abstract][Full Text] [Related]
4. Determinant factors for mortality during treatment among tuberculosis patients: Cox proportional hazards model.
Abedi S; Moosazadeh M; Afshari M; Charati JY; Nezammahalleh A
Indian J Tuberc; 2019 Jan; 66(1):39-43. PubMed ID: 30797281
[TBL] [Abstract][Full Text] [Related]
5. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
6. Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013.
Zhu L; Yang YZ; Guan HY; Cheng SM; Jin YY; Tan WG; Wu QF; Liu XL; Zhao MG; Lu ZH; Jia ZW
Int J Tuberc Lung Dis; 2017 Jul; 21(7):759-765. PubMed ID: 28633700
[TBL] [Abstract][Full Text] [Related]
7. Mortality among tuberculosis patients in the Democratic Republic of Congo.
Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
[TBL] [Abstract][Full Text] [Related]
8. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
Shibabaw A; Gelaw B; Wang SH; Tessema B
PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
[TBL] [Abstract][Full Text] [Related]
9. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
Cox H; Hughes J; Daniels J; Azevedo V; McDermid C; Poolman M; Boulle A; Goemaere E; van Cutsem G
Int J Tuberc Lung Dis; 2014 Apr; 18(4):441-8. PubMed ID: 24670700
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of drug resistant tuberculosis among patients at high-risk for Hiv attending outpatient clinics in Delhi, India.
Magee MJ; Blumberg HM; Broz D; Furner SE; Samson L; Singh S; Hershow RC
Southeast Asian J Trop Med Public Health; 2012 Mar; 43(2):354-63. PubMed ID: 23082587
[TBL] [Abstract][Full Text] [Related]
11. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes.
Mor Z; Goldblatt D; Kaidar-Shwartz H; Cedar N; Rorman E; Chemtob D
Int J Tuberc Lung Dis; 2014 Oct; 18(10):1195-201. PubMed ID: 25216833
[TBL] [Abstract][Full Text] [Related]
12. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
Tiwari S; Kumar A; Kapoor SK
Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
[TBL] [Abstract][Full Text] [Related]
13. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E
Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
[TBL] [Abstract][Full Text] [Related]
15. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
Adane K; Spigt M; Dinant GJ
BMC Pulm Med; 2018 Feb; 18(1):37. PubMed ID: 29463234
[TBL] [Abstract][Full Text] [Related]
17. Time to sputum culture conversion and treatment outcome among the first cohort of multidrug resistant tuberculosis patients in a high burden country.
Ige OM; Oladokun RE
Indian J Tuberc; 2018 Oct; 65(4):322-328. PubMed ID: 30522620
[TBL] [Abstract][Full Text] [Related]
18. Mortality of tuberculosis patients during treatment in Israel, 2000-2010.
Shuldiner J; Leventhal A; Chemtob D; Mor Z
Int J Tuberc Lung Dis; 2014 Jul; 18(7):818-23. PubMed ID: 24902558
[TBL] [Abstract][Full Text] [Related]
19. Risk factors affecting the mortality of HIV-infected patients with pulmonary tuberculosis in the cART era: a retrospective cohort study in China.
Ji YJ; Liang PP; Shen JY; Sun JJ; Yang JY; Chen J; Qi TK; Wang ZY; Song W; Tang Y; Liu L; Zhang RF; Shen YZ; Lu HZ
Infect Dis Poverty; 2018 Mar; 7(1):25. PubMed ID: 29587840
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)].
Chevalier B; Margery J; Sane M; Camara P; Lefebvre N; Gueye M; Thiam M; Perrier-Gros-Claude JD; Simon F; Fabre M; Soler C; Herve V; Mbaye PS; Debonne JM
Rev Pneumol Clin; 2010 Sep; 66(4):266-71. PubMed ID: 20933169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
